Clinical Trials
29 trialsNCT04174599 2025-04-20
Study to Compare the Efficacy and Safety of F-627 and GRAN®
EVIVE Biotechnology
Phase 3 Completed
NCT05283616 2024-03-19
Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3 Completed
NCT03252431 2023-07-03
Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
EVIVE Biotechnology
Phase 3 Completed
NCT05221593 2022-10-21
Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients
Al-Azhar University
Phase 3 Completed
NCT02643420 2022-03-02
ADVANCE
Spectrum Pharmaceuticals, Inc
Phase 3 Completed
NCT02953340 2022-03-02
SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide
Spectrum Pharmaceuticals, Inc
Phase 3 Completed
NCT02467868 2022-02-14
Efficacy and Safety Study With MYL-1401H and Neulasta
Viatris Inc.
Phase 3 Completed
NCT04466137 2022-02-09
Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy
Xiamen Amoytop Biotech Co., Ltd.
Phase 3 Completed
NCT02872103 2021-05-05
Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
EVIVE Biotechnology
Phase 3 Completed
NCT01307579 2021-03-30
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia
Children's Oncology Group
Phase 3 Completed
NCT03343145 2020-12-28
A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients
Dong-A ST Co., Ltd.
Phase 3 Completed
NCT01371656 2020-12-07
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Children's Oncology Group
Phase 3 Completed
NCT00911170 2017-12-29
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
Amgen
Phase 3 Completed
NCT01516736 2017-08-30
PROTECT2
Sandoz
Phase 3 Completed
NCT01735175 2017-08-07
PROTECT-1
Sandoz
Phase 3 Completed
NCT00044486 2017-03-10
Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT02104830 2016-10-24
Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients
Biocad
Phase 3 Completed
NCT01519700 2015-05-06
PIONEER
Sandoz
Phase 3 Completed
NCT00003739 2014-02-14
Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
Children's Oncology Group
Phase 3 Completed
NCT00035594 2013-05-09
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
Amgen
Phase 3 Completed
NCT00008359 2013-01-18
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT01611051 2013-01-08
A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Completed
NCT00003938 2012-09-24
Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00002719 2012-07-02
Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00770172 2011-05-13
G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy
National Cancer Institute (NCI)
Phase 3 Completed
NCT01285219 2011-01-27
A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy
ChineseAMS
Phase 3 Completed
NCT00117910 2008-05-16
Treatment for Elderly Patients With High Risk Breast Cancer
Amgen
Phase 3 Completed
NCT00001338 2008-03-04
A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00002277 2005-06-24
A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections
NIH AIDS Clinical Trials Information Service
Phase 3 Completed